weSRCH App on Apple

Summary of Medical Research Postings at weSRCH.com for the week of December 3, 2008 WildPhotons: sweetening another's pain

  2045      Nov 30, -0001
Corporate Performance in Clinical Trials & Drug Approval Progress Monitoring India's Pharmaceutical Industry: R&D, Manufacturing, & Marketing Opportunities Fact Sheet: Genes & Personalized Medicine Amplifing 500bp double-stranded DNA to form Nanotubes Lyme Borreliosis, Lyme Arthritis, Erythema Migrans with Polyarthritis
About weVISION: weQuest's are written by G Dan Hutcheson, his career spans more than thirty years, in which he became a well-known as a visionary for helping companies make businesses out of technology. This includes hundreds of successful programs involving product development, positioning, and launch in Semiconductor, Technology, Medicine, Energy, Business, High Tech, Enviorntment, Electronics, healthcare and Business devisions.

You may like this also:

Regulatory Science for R&D Promotion

At present, the nation’s policy for Research and Development (R&D) promotion of innovative pharmaceuticals & improvement of environments for the R&D is formulated by Japanese gover

18 August, 2019
16 August, 2019

Stewards of High-Value Imaging

This project helped strengthen the relationship between the radiologists and ED physicians and set the stage for increased collaboration over time.

15 August, 2019
Kosuke Lijima
14 August, 2019
13 August, 2019
13 August, 2019

Antimicrobial Resistance Strategy and Use

Determined by the quality of the antimicrobial and by the distribution, prescription, and administration of veterinary medicinal products containing antimicrobial agents.

Matthew Stone
13 August, 2019
12 August, 2019
weSRCH App on Apple

Recent weVISIONs

Tom Caulfield on what's next at GLOBALFOUNDRIES
22 July, 2019
IBM Research AI Hardware Center ... with Mukesh Khare of IBM
Mukesh V. KhareIBM
20 May, 2019